Boeing Company (The) (BA) › Analysis

Boeing Company (The) (BA) analysis, July 31, 2026

Published July 31, 2026 · BA chart, levels and live analysis

Executive Summary

Boeing shares declined 2.93% to $213.05 since the prior report, reversing the previous session's rebound with a sharp 3.55% intraday drop on July 31 despite securing 173 aircraft orders at the Farnborough Airshow and posting improved second-quarter delivery volumes. The pullback indicates persistent investor caution regarding the timeline for sustained profitability, as management reiterated that financial repair must precede any new aircraft program and the company recorded another quarterly loss.

Key Updates

Since the July 30 report, BA has given back its 2.58% advance, falling to $213.05 and erasing the rebound tied to Morningstar's fair value revision. The decline follows the release of second-quarter results showing a net loss of $322 million per Morningstar and $428 million per Business Insider, alongside $24.6 billion in revenue and an $280 million Air Force One charge. Operational metrics showed sequential improvement: 171 aircraft delivered in Q2, up 12% year-over-year, with 314 jets delivered in the first half of 2026, the best H1 performance since 2018. Boeing dominated the Farnborough Airshow with 173 orders against Airbus's 154, including 100 planes from SMBC Aviation Capital and 28 Boeing 787s for Riyadh Air. However, CEO Kelly Ortberg emphasized that the company requires "a couple more years" to repair its balance sheet before funding a new commercial aircraft program, targeting 2030 for financial readiness. The company aims to increase 737 MAX production from 42 toward 47 by late 2026 and eventually to 52 per month, supported by a new Everett production line and a backlog of nearly 7,000 aircraft. Certification for the 737 MAX 7, MAX 10, and 777X remains expected later in 2026, with management guiding to approximately $1.5 billion in 2026 free cash flow and a path toward exceeding $10 billion by 2028.

Current Trend

Boeing remains in a consolidation phase with a year-to-date decline of 1.87% and a six-month decline of 8.84%, underperforming on a medium-term horizon. The stock has exhibited elevated volatility over the past week, swinging between approximately $213 and $220. The July 31 drop of 3.55% suggests selling pressure near the $220 resistance zone, while the $213 level may act as near-term support given its proximity to the current quote and the one-month low context. The five-day performance of +1.68% masks this intraday reversal, indicating indecision among market participants as operational improvements clash with ongoing losses and delayed new program timelines.

Investment Thesis

The investment thesis centers on Boeing's multi-year operational turnaround under CEO Kelly Ortberg, underpinned by production rate recovery, certification of delayed variants, and conversion of a record backlog into free cash flow. The company-specific catalysts include ramping 737 MAX output from 42 to 47 by late 2026 and toward 52 longer-term, certification of the 777X and 737 MAX-7/MAX-10 later this year, and $1.5 billion in projected 2026 free cash flow. Market-wide demand remains robust, evidenced by 173 Farnborough orders and a backlog near 7,000 aircraft, though near-term profitability is constrained by a $1 billion Everett facility investment and continued defense segment charges. The delay of any new clean-sheet aircraft until approximately 2030 removes near-term R&D risk but leaves Boeing dependent on the current product cycle to drive financial repair.

Thesis Status

The thesis remains intact but execution risk has increased. The Farnborough order victory and improved H1 deliveries validate the operational recovery narrative, yet the stock's inability to hold gains above $219 signals market skepticism toward the pace of margin expansion. Management's explicit guidance that a new aircraft program is years away reinforces the view that Boeing is a cash-flow recovery story rather than a growth story for the remainder of the decade. The revised Morningstar fair value of $246 implies roughly 15% upside from current levels, but the path depends on hitting second-half cash flow positivity and certification milestones in late 2026.

Key Drivers

Technical Analysis

The current price action shows a rejection at the $220 resistance level, with BA closing at $213.05 on July 31 after a 3.55% intraday decline. This level now represents immediate support; a sustained break below could expose the stock to retest six-month lows given the 8.84% decline over that period. Resistance is firmly established near $220-$221, where the prior two reports recorded prices of $219.48 and $220.32. The YTD decline of 1.87% indicates a neutral-to-negative long-term bias, while the five-day gain of 1.68% has been entirely reversed by the latest session, suggesting weak bullish conviction. Volume-driven selling on July 31 warrants monitoring for follow-through.

Bull Case

Bear Case

Get a message when the BA picture changes — the agent team watches the levels and the news for you.Create a free account

More BA analyses